Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways1

Abstract Dent, P., Yacoub, A., Contessa, J., Caron, R., Amorino, G., Valerie, K., Hagan, M. P., Grant, S. and Schmidt-Ullrich, R. Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways. Radiat. Res. 159, 283–300 (2003). Exposure of cells to a variety of stresses induces compensatory activations of multiple intracellular signaling pathways. These activations can play critical roles in controlling cell survival and repopulation effects in a stress-specific and cell type-dependent manner. Some stress-induced signaling pathways are those normally activated by mitogens such as the EGFR/RAS/PI3K-MAPK pathway. Other pathways activated by stresses such as ionizing radiation include those downstream of death receptors, including pro-caspases and the transcription factor NFKB. This review will attempt to describe some of the complex network of signals induced by ionizing radiation and other cellular stresses in animal cells, with particular attention to signaling by growth factor and death receptors. This includes radiation-induced signaling via the EGFR and IGFI-R to the PI3K, MAPK, JNK, and p38 pathways as well as FAS-R and TNF-R signaling to pro-caspases and NFKB. The roles of autocrine ligands in the responses of cells and bystander cells to radiation and cellular stresses will also be discussed. Based on the data currently available, it appears that radiation can simultaneously activate multiple signaling pathways in cells. Reactive oxygen and nitrogen species may play an important role in this process by inhibiting protein tyrosine phosphatase activity. The ability of radiation to activate signaling pathways may depend on the expression of growth factor receptors, autocrine factors, RAS mutation, and PTEN expression. In other words, just because pathway X is activated by radiation in one cell type does not mean that pathway X will be activated in a different cell type. Radiation-induced signaling through growth factor receptors such as the EGFR may provide radioprotective signals through multiple downstream pathways. In some cell types, enhanced basal signaling by proto-oncogenes such as RAS may provide a radioprotective signal. In many cell types, this may be through PI3K, in others potentially by NFKB or MAPK. Receptor signaling is often dependent on autocrine factors, and synthesis of autocrine factors will have an impact on the amount of radiation-induced pathway activity. For example, cells expressing TGFα and HB-EGF will generate protection primarily through EGFR. Heregulin and neuregulins will generate protective signals through ERBB4/ERBB3. The impact on radiation-induced signaling of other autocrine and paracrine ligands such as TGFβ and interleukin 6 is likely to be as complicated as described above for the ERBB receptors.

[1]  C. Cori,et al.  CRYSTALLINE MUSCLE PHOSPHORYLASE , 1942 .

[2]  C. Cori,et al.  THE ENZYMATIC CONVERSION OF PHOSPHORYLASE a TO b , 1945 .

[3]  E. Krebs,et al.  The phosphorylase b to a converting enzyme of rabbit skeletal muscle. , 1956, Biochimica et biophysica acta.

[4]  Leloir Lf Regulation of glycogen metabolism. , 1967 .

[5]  E. Krebs,et al.  An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. , 1968, The Journal of biological chemistry.

[6]  E. Krebs,et al.  Amino acid sequence of the phosphorylated site in rabbit liver glycogen phosphorylase. , 1970, Biochemistry.

[7]  E. Sutherland On the biological role of cyclic AMP. , 1970, JAMA.

[8]  E. Krebs,et al.  The regulation of skeletal muscle phosphorylase kinase by Ca2+. , 1971, The Journal of biological chemistry.

[9]  G. Rindi [The biological role of cyclic AMP]. , 1971, Acta diabetologica latina.

[10]  J. Larner, COVALENT AND NONCOVALENT CONTROL OF GLYCOGEN SYNTHESIS * , 1973, Annals of the New York Academy of Sciences.

[11]  P. Greengard,et al.  Ca2+-dependent protein phosphorylation system in membranes from various tissues, and its activation by "calcium-dependent regulator". , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[12]  R. Erikson,et al.  Avian sarcoma virus-transforming protein, pp60src shows protein kinase activity specific for tyrosine , 1980, Nature.

[13]  R. Weinberg,et al.  Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene , 1982, Nature.

[14]  S. Cohen The receptor for epidermal growth factor functions as a tyrosyl-specific kinase. , 1983, Progress in nucleic acid research and molecular biology.

[15]  Jonathan A. Cooper,et al.  C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity. , 1984, The Journal of biological chemistry.

[16]  M. Berridge,et al.  Inositol trisphosphate formation and calcium mobilization in Swiss 3T3 cells in response to platelet-derived growth factor. , 1984, The Biochemical journal.

[17]  R. Cooper,et al.  Inositol trisphosphate and diacylglycerol as intracellular second messengers in liver. , 1985, The American journal of physiology.

[18]  T. Sturgill,et al.  Muscle proteins related to microtubule associated protein-2 are substrates for an insulin-stimulatable kinase. , 1986, Biochemical and biophysical research communications.

[19]  J. Maller,et al.  Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II , 1988, Nature.

[20]  P. Casey,et al.  G proteins control diverse pathways of transmembrane signaling 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  M. Waterfield,et al.  Structural basis for epidermal growth factor receptor function. , 1989, Progress in growth factor research.

[22]  Growth factor signaling pathways: phosphoinositide metabolism and phosphorylation of phospholipase C. , 1989, Cancer cells.

[23]  M. Hung,et al.  Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. , 1989, Oncogene.

[24]  M. Cobb,et al.  Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. , 1991, Cell regulation.

[25]  H. Michel,et al.  Renaturation and partial peptide sequencing of mitogen-activated protein kinase (MAP kinase) activator from rabbit skeletal muscle. , 1992, The Biochemical journal.

[26]  K. Valerie,et al.  Expression of oestrogen receptor and transforming growth factor-alpha in MCF-7 cells after exposure to fractionated irradiation. , 1992, International journal of radiation biology.

[27]  T. Haystead,et al.  Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. , 1992, Science.

[28]  David L. Brautigan,et al.  Raf-1 activates MAP kinase-kinase , 1992, Nature.

[29]  R. Frye Involvement of G proteins, cytoplasmic calcium, phospholipases, phospholipid-derived second messengers, and protein kinases in signal transduction from mitogenic cell surface receptors. , 1992, Cancer treatment and research.

[30]  M. Cobb,et al.  Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. , 1993, The Journal of biological chemistry.

[31]  M. Weber,et al.  Complexes of Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase. , 1993, Science.

[32]  P. Dent,et al.  Identification and characterization of a new mammalian mitogen-activated protein kinase kinase, MKK2 , 1993, Molecular and cellular biology.

[33]  Nanxin Li,et al.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling , 1993, Nature.

[34]  E. Hafen,et al.  A Drosophila SH2-SH3 adaptor protein implicated in coupling the sevenless tyrosine kinase to an activator of Ras guanine nucleotide exchange, Sos , 1993, Cell.

[35]  Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase. , 1993, Molecular and cellular biology.

[36]  M. Wigler,et al.  Complex formation between RAS and RAF and other protein kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Karin,et al.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. , 1993, Genes & development.

[38]  T. Haystead,et al.  Functional expression of a MAP kinase kinase in COS cells and recognition by an anti‐STE7/byrl antibody , 1993, FEBS letters.

[39]  Sally J. Leevers,et al.  Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane , 1994, Nature.

[40]  E. Peles,et al.  ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. , 1994, The Journal of biological chemistry.

[41]  R. Challiss,et al.  Phosphoinositide-derived second messengers and the regulation of Ca2+ in vascular smooth muscle. , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[42]  Activation of (His)6-Raf-1 in vitro by partially purified plasma membranes from v-Ras-transformed and serum-stimulated fibroblasts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[43]  M. Karin,et al.  JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain , 1994, Cell.

[44]  L Bibbs,et al.  A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. , 1994, Science.

[45]  W. Dougall,et al.  Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Karin,et al.  Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. , 1995, Science.

[47]  D. Noh,et al.  Phosphoinositide-specific phospholipase C and mitogenic signaling. , 1995, Biochimica et biophysica acta.

[48]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[49]  C. Marshall,et al.  Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation. , 1995, The EMBO journal.

[50]  D. Morrison,et al.  Reversal of Raf-1 activation by purified and membrane-associated protein phosphatases. , 1995, Science.

[51]  Jiahuai Han,et al.  Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.

[52]  A. Thomason,et al.  Transformation of NIH 3T3 Cells by HER3 or HER4 Receptors Requires the Presence of HER1 or HER2 (*) , 1996, The Journal of Biological Chemistry.

[53]  P. Cohen,et al.  Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinase , 1996, FEBS letters.

[54]  J. Baselga,et al.  Autocrine Regulation of Membrane Transforming Growth Factor- Cleavage (*) , 1996, The Journal of Biological Chemistry.

[55]  K. Carraway Involvement of the neuregulins and their receptors in cardiac and neural development. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[56]  H. Warenius,et al.  Exit from G2 phase after 2 Gy gamma irradiation is faster in radiosensitive human cells with high expression of the RAF1 proto-oncogene. , 1996, Radiation research.

[57]  W. A. Yeudall,et al.  Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. , 1996, Oncogene.

[58]  M. Shannon,et al.  The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. , 1996, Biochimica et biophysica acta.

[59]  Kuo‐Ting Chang,et al.  Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells. , 1996, Cancer research.

[60]  R. Schmidt-Ullrich,et al.  Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. , 1996, Radiation research.

[61]  A. Fornace,et al.  Signaling events controlling the molecular response to genotoxic stress. , 1996, EXS.

[62]  M. McMahon,et al.  Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 , 1997, Oncogene.

[63]  G. Cooper,et al.  Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase , 1997, Molecular and cellular biology.

[64]  B. Kavanagh,et al.  Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation , 1997, Oncogene.

[65]  P. Dent,et al.  Association of Grb2 with Sos and Ras with Raf-1 upon gamma irradiation of breast cancer cells , 1997, Oncogene.

[66]  R. Kolesnick,et al.  Kinase Suppressor of Ras Is Ceramide-Activated Protein Kinase , 1997, Cell.

[67]  J. Baselga,et al.  PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[68]  F. McCormick,et al.  Activation of c‐Raf‐1 by Ras and Src through different mechanisms: activation in vivo and in vitro , 1997, The EMBO journal.

[69]  J. Downward,et al.  Interaction of Ras with phosphoinositide 3-kinase gamma. , 1997, The Biochemical journal.

[70]  C. Marshall,et al.  Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases* , 1997, The Journal of Biological Chemistry.

[71]  G. Müller,et al.  Regulation of Raf‐1 kinase by TNF via its second messenger ceramide and cross‐talk with mitogenic signalling , 1998, The EMBO journal.

[72]  Brendan D. Price,et al.  The DNA-Dependent Protein Kinase Participates in the Activation of NFκB Following DNA Damage , 1998 .

[73]  A. Lenferink,et al.  The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin , 1998, Oncogene.

[74]  P. Sassone-Corsi,et al.  Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[75]  D. Alessi,et al.  Mitogen‐ and stress‐activated protein kinase‐1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB , 1998, The EMBO journal.

[76]  J C Reed,et al.  Dysregulation of apoptosis in cancer. , 1998, The cancer journal from Scientific American.

[77]  P. Fisher,et al.  Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells , 1998, Oncogene.

[78]  David I. Smith,et al.  Analysis of EGF receptor amplicons reveals amplification of multiple expressed sequences , 1998, Oncogene.

[79]  J. Downward,et al.  Protein Kinase B Activation and Lamellipodium Formation Are Independent Phosphoinositide 3-Kinase-Mediated Events Differentially Regulated by Endogenous Ras , 1998, Molecular and Cellular Biology.

[80]  R. Schmidt-Ullrich,et al.  Calcium-dependent stimulation of mitogen-activated protein kinase activity in A431 cells by low doses of ionizing radiation. , 1998, Radiation research.

[81]  Joseph Avruch,et al.  A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity , 1998, Nature.

[82]  P. Graves,et al.  14-3-3 Proteins Are Required for Maintenance of Raf-1 Phosphorylation and Kinase Activity , 1998, Molecular and Cellular Biology.

[83]  Specific, irreversible inhibitors of the epidermal growth factor receptor [EGFR] family of tyrosine kinases , 1998 .

[84]  Yi-Hsien Su,et al.  Suppression of transforming growth factor-β-induced apoptosis through a phosphatidylinositol 3-kinase/Akt-dependent pathway , 1998, Oncogene.

[85]  J. Ross,et al.  The HER‐2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy , 1998, Stem cells.

[86]  G. Johnson,et al.  The TAO of MEKK. , 1998, Frontiers in bioscience : a journal and virtual library.

[87]  A. Hamburger,et al.  The use of the yeast two hybrid system to evaluate ErbB-3 interactions with SH2 domain containing proteins. , 1998, Biochemical and biophysical research communications.

[88]  L. Pirola,et al.  Structure and function of phosphoinositide 3-kinases. , 1998, Biochimica et biophysica acta.

[89]  C. Dean,et al.  Two erbB-4 transcripts are expressed in normal breast and in most breast cancers , 1998, Oncogene.

[90]  V. Jordan,et al.  The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor. , 1998, British Journal of Cancer.

[91]  C. Marshall,et al.  Activation of the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathway by Conventional, Novel, and Atypical Protein Kinase C Isotypes , 1998, Molecular and Cellular Biology.

[92]  J. Troppmair,et al.  Activation of NF-κB by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade , 1998, Oncogene.

[93]  P. Besmer,et al.  Kit signaling through PI 3‐kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation , 1998, The EMBO journal.

[94]  A. Sharrocks,et al.  Differential targeting of MAP kinases to the ETS‐domain transcription factor Elk‐1 , 1998, The EMBO journal.

[95]  R. Epstein,et al.  Proxy activation of protein ErbB2 by heterologous ligands implies a heterotetrameric mode of receptor tyrosine kinase interaction. , 1998, The Biochemical journal.

[96]  Gordon Mills,et al.  Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC , 1998, Current Biology.

[97]  A. Bridges The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases. , 1999, Current medicinal chemistry.

[98]  J. Settleman,et al.  The Drosophila Pkn protein kinase is a Rho/Rac effector target required for dorsal closure during embryogenesis. , 1999, Genes & development.

[99]  U. Kikkawa,et al.  Akt phosphorylation site found in human caspase-9 is absent in mouse caspase-9. , 1999, Biochemical and biophysical research communications.

[100]  A. Hamburger,et al.  ErbB‐2 kinase is required for constitutive stat 3 activation in malignant human lung epithelial cells , 1999, International journal of cancer.

[101]  R. Schmidt-Ullrich,et al.  Roles for basal and stimulated p21(Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells. , 1999, Molecular biology of the cell.

[102]  G. Cooper,et al.  B-Raf Inhibits Programmed Cell Death Downstream of Cytochrome c Release from Mitochondria by Activating the MEK/Erk Pathway , 1999, Molecular and Cellular Biology.

[103]  R. Davis,et al.  Signal transduction by the c-Jun N-terminal kinase. , 1999, Biochemical Society symposium.

[104]  P. Agostinis,et al.  JNK/SAPK activation by platelet-derived growth factor in A431 cells requires both the phospholipase C-gamma and the phosphatidylinositol 3-kinase signaling pathways of the receptor. , 1999, Biochemical and biophysical research communications.

[105]  Derek W. Abbott,et al.  Mitogen-activated Protein Kinase Kinase 2 Activation Is Essential for Progression through the G2/M Checkpoint Arrest in Cells Exposed to Ionizing Radiation* , 1999, The Journal of Biological Chemistry.

[106]  T. Grunt,et al.  Expression of c-erbB-41HER4 Is Regulated in T47D Breast Carcinoma Cells by Retinoids and Vitamin D31 , 1999 .

[107]  R. Schmidt-Ullrich,et al.  Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. , 1999, Molecular biology of the cell.

[108]  Brian A. Hemmings,et al.  Domain Swapping Used To Investigate the Mechanism of Protein Kinase B Regulation by 3-Phosphoinositide-Dependent Protein Kinase 1 and Ser473 Kinase , 1999, Molecular and Cellular Biology.

[109]  Yoshiyuki Kuchino,et al.  Regulation of c-Myc through Phosphorylation at Ser-62 and Ser-71 by c-Jun N-Terminal Kinase* , 1999, The Journal of Biological Chemistry.

[110]  A. Mathieu,et al.  Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells , 1999, Cell Death and Differentiation.

[111]  C. M. Davenport,et al.  Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. , 1999, Science.

[112]  M. Vandenplas,et al.  Atypical PKC ζ is activated by ceramide, resulting in coactivation of NF‐κb/JNK kinase and cell survival , 1999 .

[113]  D. Baldwin,et al.  RIP2 Is a Raf1-activated Mitogen-activated Protein Kinase Kinase* , 1999, The Journal of Biological Chemistry.

[114]  E. Vellenga,et al.  Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL-6 expression in human monocytes. , 1999, Journal of immunology.

[115]  M. Diaz-Meco,et al.  Inactivation of the Inhibitory κB Protein Kinase/Nuclear Factor κB Pathway by Par-4 Expression Potentiates Tumor Necrosis Factor α-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[116]  K. Moelling,et al.  Phosphorylation and regulation of Raf by Akt (protein kinase B). , 1999, Science.

[117]  J. Barnard,et al.  Heparin Binding Epidermal Growth Factor-like Growth Factor Is a Transforming Growth Factor β-Regulated Gene in Intestinal Epithelial Cells , 1999 .

[118]  Bernhard O. Palsson,et al.  Cancer cell lines , 1999 .

[119]  M. Serrano,et al.  The downregulation of the pro‐apoptotic protein Par‐4 is critical for Ras‐induced survival and tumor progression , 1999, The EMBO journal.

[120]  H. Wakita,et al.  Activation of Epidermal Growth Factor Receptor Promotes Late Terminal Differentiation of Cell-Matrix Interaction-disrupted Keratinocytes* , 1999, The Journal of Biological Chemistry.

[121]  Heparin binding epidermal growth factor-like growth factor is a transforming growth factor beta-regulated gene in intestinal epithelial cells. , 1999, Biochemical and biophysical research communications.

[122]  D. Stern,et al.  Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation , 1999, Oncogene.

[123]  J. Hancock,et al.  Interactions of c-Raf-1 with phosphatidylserine and 14-3-3 , 1999, Oncogene.

[124]  Y. Yarden,et al.  The C‐terminus of the kinase‐defective neuregulin receptor ErbB‐3 confers mitogenic superiority and dictates endocytic routing , 1999, The EMBO journal.

[125]  S. Yeh,et al.  From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[126]  R. Schmidt-Ullrich,et al.  The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[127]  T. Grunt,et al.  Expression of c-erbB-4/HER4 is regulated in T47D breast carcinoma cells by retinoids and vitamin D3. , 1999, Biochemical and biophysical research communications.

[128]  Monilola A. Olayioye,et al.  NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways , 1999, Oncogene.

[129]  C. Tournier,et al.  The MKK7 Gene Encodes a Group of c-Jun NH2-Terminal Kinase Kinases , 1999, Molecular and Cellular Biology.

[130]  G Bartsch,et al.  Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. , 1999, Cancer research.

[131]  J. Contessa,et al.  Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells , 1999, Oncogene.

[132]  V. Rangnekar,et al.  Negative regulation of Par-4 by oncogenic Ras is essential for cellular transformation , 1999, Oncogene.

[133]  W. Earnshaw,et al.  Induction of apoptosis by cancer chemotherapy. , 2000, Experimental cell research.

[134]  H. Hosick,et al.  Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[135]  L. Norton,et al.  Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[136]  B. Lehnert,et al.  Factors underlying the cell growth-related bystander responses to alpha particles. , 2000, Cancer research.

[137]  B. Neel,et al.  New Role for Shc in Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway , 2000, Molecular and Cellular Biology.

[138]  H. Kung,et al.  KFC, a Ste20-like kinase with mitogenic potential and capability to activate the SAPK/JNK pathway , 2000, Oncogene.

[139]  I. Fidler,et al.  Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. , 2000, Cancer research.

[140]  S. Ethier,et al.  Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor. , 2000, International journal of radiation oncology, biology, physics.

[141]  K. Valerie,et al.  Role of the p38 and MEK-½/p42/44 MAP Kinase Pathways in the Differential Activation of Human Immunodeficiency Virus Gene Expression by Ultraviolet and Ionizing Radiation , 2000 .

[142]  Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements. , 2000, Neuro-oncology.

[143]  John Mendelsohn,et al.  The EGF receptor family as targets for cancer therapy , 2000, Oncogene.

[144]  A. Bridges,et al.  Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenografts , 2000, Cancer Chemotherapy and Pharmacology.

[145]  D. Alessi,et al.  Further evidence that 3‐phosphoinositide‐dependent protein kinase‐1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms , 2000, FEBS letters.

[146]  R. Muschel,et al.  RAS-Mediated Radiation Resistance is not Linked to MAP Kinase Activation in Two Bladder Carcinoma Cell Lines , 2000, Radiation research.

[147]  D. Bonneau,et al.  Mutations of the human PTEN gene , 2000, Human mutation.

[148]  E. Van Obberghen,et al.  Effect of Phosphoinositide-Dependent Kinase 1 on Protein Kinase B Translocation and Its Subsequent Activation , 2000, Molecular and Cellular Biology.

[149]  D. Stern Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases , 2000, Breast Cancer Research.

[150]  G. Tzivion,et al.  Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association. , 2000, The Biochemical journal.

[151]  K. Carraway,et al.  Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage , 2000, Oncogene.

[152]  E. Mekada,et al.  Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. , 2000, Cancer research.

[153]  John Calvin Reed,et al.  MEK/ERK signaling pathway regulates the expression of Bcl‐2, Bcl‐XL, and Mcl‐1 and promotes survival of human pancreatic cancer cells , 2000, Journal of cellular biochemistry.

[154]  Paul Dent,et al.  Signal Transduction and Cellular Radiation Responses , 2000, Radiation research.

[155]  M. Hung,et al.  HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB Pathway* , 2000, The Journal of Biological Chemistry.

[156]  J. M. Lin,et al.  Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines. , 2000, The Prostate.

[157]  D. Slamon,et al.  Trastuzumab and chemotherapeutics: drug interactions and synergies. , 2000, Seminars in Oncology.

[158]  A. King,et al.  Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak , 2000, Current Biology.

[159]  M. Mattson,et al.  Pro‐apoptotic action of PAR‐4 involves inhibition of NF‐κB activity and suppression of BCL‐2 expression , 2000, Journal of neuroscience research.

[160]  M. Klagsbrun,et al.  A Natural ErbB4 Isoform That Does Not Activate Phosphoinositide 3-Kinase Mediates Proliferation but Not Survival or Chemotaxis* , 2000, The Journal of Biological Chemistry.

[161]  Donald M. O'Rourke,et al.  Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo , 2000, Nature Biotechnology.

[162]  B. Vanhaesebroeck,et al.  The PI3K-PDK1 connection: more than just a road to PKB. , 2000, The Biochemical journal.

[163]  M. C. Hu,et al.  HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. , 2000, The Journal of biological chemistry.

[164]  Careen K. Tang,et al.  Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. , 2000, Cancer research.

[165]  M. Kris,et al.  Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[166]  K. Valerie,et al.  Role of the p38 and MEK‐½/p42/44 MAP Kinase Pathways in the Differential Activation of Human Immunodeficiency Virus Gene Expression by Ultraviolet and Ionizing Radiation , 2000, Photochemistry and photobiology.

[167]  P. Dent,et al.  Ionizing Radiation-Induced Mitogen-Activated Protein (MAP) Kinase Activation in DU145 Prostate Carcinoma Cells: MAP Kinase Inhibition Enhances Radiation-Induced Cell Killing and G2/M-Phase Arrest , 2000 .

[168]  A. Schulze,et al.  Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. , 2000, Genes & development.

[169]  Jiahuai Han,et al.  Involvement of the MKK6-p38γ Cascade in γ-Radiation-Induced Cell Cycle Arrest , 2000, Molecular and Cellular Biology.

[170]  Jing Chen,et al.  Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK–ERK independent mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[171]  S. Paik,et al.  HER-2 and choice of adjuvant chemotherapy in breast cancer. , 2001, Seminars in oncology.

[172]  J. Santibañez,et al.  ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS‐2 cell line , 2001, Journal of cellular biochemistry.

[173]  Y. Qiu,et al.  Regulation of Akt/PKB Activation by Tyrosine Phosphorylation* , 2001, The Journal of Biological Chemistry.

[174]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[175]  J. Baselga,et al.  Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. , 2001, Cancer research.

[176]  T. Suhara,et al.  Phosphatidylinositol 3-Kinase/Akt Signaling Controls Endothelial Cell Sensitivity to Fas-Mediated Apoptosis via Regulation of FLICE-Inhibitory Protein (FLIP) , 2001, Circulation research.

[177]  U. Rodeck,et al.  Epidermal Growth Factor Receptor-dependent Control of Keratinocyte Survival and Bcl-xL Expression through a MEK-dependent Pathway* , 2001, The Journal of Biological Chemistry.

[178]  J. Baselga,et al.  Mechanism of action of anti-HER2 monoclonal antibodies. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[179]  L. Cantley,et al.  ERK Regulates the Hepatocyte Growth Factor-mediated Interaction of Gab1 and the Phosphatidylinositol 3-Kinase* , 2001, The Journal of Biological Chemistry.

[180]  J. Avruch,et al.  Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.

[181]  E. Maizels,et al.  Developmental regulation of mitogen-activated protein kinase-activated kinases-2 and -3 (MAPKAPK-2/-3) in vivo during corpus luteum formation in the rat. , 2001, Molecular endocrinology.

[182]  L. Mahadevan,et al.  Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha ) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts. , 2001, The Journal of biological chemistry.

[183]  L. Mahadevan,et al.  Combinations of ERK and p38 MAPK Inhibitors Ablate Tumor Necrosis Factor-α (TNF-α) mRNA Induction , 2001, The Journal of Biological Chemistry.

[184]  G. Mills,et al.  Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells , 2001, British Journal of Cancer.

[185]  V. Rangnekar,et al.  Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. , 2001, Cancer research.

[186]  J. Smyth,et al.  Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer. , 2001, Cancer research.

[187]  Ming-Tsan Lin,et al.  The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6 , 2001, Oncogene.

[188]  G. Ramadori,et al.  in spontaneous apoptosis and in the anti-apoptotic effect of TGF-b or TNF-a on activated hepatic stellate cells , 2001 .

[189]  R. Schmidt-Ullrich,et al.  The relative role of ErbB1–4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells , 2001, Oncogene.

[190]  D. W. Fry,et al.  Akt, MAPK (Erk1/2), and p38 Act in Concert to Promote Apoptosis in Response to ErbB Receptor Family Inhibition* , 2001, The Journal of Biological Chemistry.

[191]  A. Scott,et al.  Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. , 2001, Cancer research.

[192]  J. Manola,et al.  Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[193]  A. Majumdar,et al.  Increased in vitro activation of EGFR by membrane-bound TGF-alpha from gastric and colonic mucosa of aged rats. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[194]  E K Rowinsky,et al.  Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[195]  N. Guitton,et al.  IL-6 a key cytokine in in vitro and in vivo response of Sertoli cells to external gamma irradiation. , 2001, Cytokine.

[196]  J. Hofsteenge,et al.  Identification of Tyrosine Phosphorylation Sites on 3-Phosphoinositide-dependent Protein Kinase-1 and Their Role in Regulating Kinase Activity* , 2001, The Journal of Biological Chemistry.

[197]  S H Kaufmann,et al.  The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux. , 2001, Cancer research.

[198]  R. Parsons,et al.  PTEN: life as a tumor suppressor. , 2001, Experimental cell research.

[199]  P. Dennis,et al.  Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2. , 2001, Cancer research.

[200]  D. Latchman,et al.  Cardioprotective Effects of Transforming Growth Factor-&bgr;1 During Early Reoxygenation or Reperfusion Are Mediated by p42/p44 MAPK , 2001, Journal of cardiovascular pharmacology.

[201]  R. Schmidt-Ullrich,et al.  Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. , 2001, Journal of the National Cancer Institute.

[202]  K. Carraway,et al.  Localization and modulation of ErbB receptor tyrosine kinases. , 2001, Current opinion in cell biology.

[203]  R. Coffey,et al.  Her-2/neu overexpression induces NF-κB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IκB-α that can be inhibited by the tumor suppressor PTEN , 2001, Oncogene.

[204]  T. Ching,et al.  Specific binding of the C-terminal Src homology 2 domain of the p85alpha subunit of phosphoinositide 3-kinase to phosphatidylinositol 3,4,5-trisphosphate. Localization and engineering of the phosphoinositide-binding motif. , 2001, The Journal of biological chemistry.

[205]  C. Leung,et al.  Epidermal growth factor induces Gadd45 (growth arrest and DNA damage inducible protein) expression in A431 cells. , 2001, Biochimica et biophysica acta.

[206]  J. Mier,et al.  Phosphatidylinositol 3-Kinase/Akt Activity Regulates c-FLIP Expression in Tumor Cells* , 2001, The Journal of Biological Chemistry.

[207]  J. Blenis,et al.  An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[208]  P. Fisher,et al.  Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. , 2001, Molecular biology of the cell.

[209]  Analysis of the transcriptional program induced by Raf in epithelial cells , 2001 .

[210]  J. Hancock,et al.  Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions , 2001, Oncogene.

[211]  M. Takigawa,et al.  CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). , 2001, European journal of biochemistry.

[212]  Kanefusa Kato,et al.  Protein kinase inhibitors can suppress stress-induced dissociation of Hsp27 , 2001, Cell stress & chaperones.

[213]  T. Tzai,et al.  Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[214]  M. Birnbaum,et al.  Neuregulin Signaling through a PI3K/Akt/Bad Pathway in Schwann Cell Survival , 2001, Molecular and Cellular Neuroscience.

[215]  Keiji Suzuki,et al.  Extremely low-dose ionizing radiation causes activation of mitogen-activated protein kinase pathway and enhances proliferation of normal human diploid cells. , 2001, Cancer research.

[216]  S. Kim,et al.  BetaPix-enhanced p38 activation by Cdc42/Rac/PAK/MKK3/6-mediated pathway. Implication in the regulation of membrane ruffling. , 2001, The Journal of biological chemistry.

[217]  K. Ang,et al.  C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability. , 2001, International journal of radiation oncology, biology, physics.

[218]  A. Schulze,et al.  Analysis of the transcriptional program induced by Raf in epithelial cells , 2001, Nature Genetics.

[219]  M. Imamura,et al.  Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells. , 2001, Anticancer research.

[220]  B. Saile The bcl, NFκB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-β or TNF-α on activated hepatic stellate cells , 2001 .

[221]  Opposing effect of p38 CCDPK and p44/42 CCDPK signaling on TNF-alpha-induced apoptosis in bovine aortic endothelial cells. , 2001, Acta pharmacologica Sinica.

[222]  J. Mendelsohn The epidermal growth factor receptor as a target for cancer therapy. , 2001, Endocrine-Related Cancer.

[223]  A. Ullrich,et al.  The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification. , 2001, Endocrine-related cancer.

[224]  G. Tortora,et al.  Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines , 2001, International journal of cancer.

[225]  M. Jo,et al.  Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells. , 2001, Journal of cell science.

[226]  W. Denny The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases. , 2001, Farmaco.

[227]  M. Denton,et al.  Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor , 2001, Oncogene.

[228]  M. Scott,et al.  The developmental biology of brain tumors. , 2001, Annual review of neuroscience.

[229]  K. Gibson,et al.  Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. , 2001, Bioorganic & medicinal chemistry letters.

[230]  M. Mattson,et al.  Effects of NF-κB1 (p50) targeted gene disruption on ionizing radiation-induced NF-κB activation and TNFα, IL-1α, IL-1β and IL-6 mRNA expression in vivo , 2001 .

[231]  P. Dent,et al.  MAPK dependence of DNA damage repair: ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion , 2001, International journal of radiation biology.

[232]  Peipei Ping,et al.  p38 Kinase-dependent MAPKAPK-2 Activation Functions as 3-Phosphoinositide-dependent Kinase-2 for Akt in Human Neutrophils* , 2001, The Journal of Biological Chemistry.

[233]  M. Jung,et al.  NF-kappa B signaling pathway as a target for human tumor radiosensitization. , 2001, Seminars in radiation oncology.

[234]  K. Moelling,et al.  Regulation of Raf by Akt Controls Growth and Differentiation in Vascular Smooth Muscle Cells* , 2001, The Journal of Biological Chemistry.

[235]  F. Aoudjit,et al.  Matrix Attachment Regulates FAS-Induced Apoptosis in Endothelial Cells , 2001, The Journal of cell biology.

[236]  B. Kahn,et al.  Differential Activation of Protein Kinase B and p70S6K by Glucose and Insulin-like Growth Factor 1 in Pancreatic β-Cells (INS-1)* , 2001, The Journal of Biological Chemistry.

[237]  Hua Yu,et al.  Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells , 2001, Oncogene.

[238]  A. Scott,et al.  Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor. , 2001, Cancer research.

[239]  R. Schmidt-Ullrich,et al.  Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[240]  R. Muschel,et al.  The Ras radiation resistance pathway. , 2001, Cancer research.

[241]  M. Sliwkowski,et al.  A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4. , 2001, Cancer research.

[242]  D. K. Kuharsky,et al.  Relief of Extrinsic Pathway Inhibition by the Bid-dependent Mitochondrial Release of Smac in Fas-mediated Hepatocyte Apoptosis* , 2002, The Journal of Biological Chemistry.

[243]  N. Rosen,et al.  Degradation of HER2 by ansamycins induces growth arrest and apoptosis in cells with HER2 overexpression via a HER3, phosphatidylinositol 3'-kinase-AKT-dependent pathway. , 2002, Cancer research.

[244]  R. Weber,et al.  Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[245]  T. Katada,et al.  Activation of Extracellular Signal-regulated Kinase by Ultraviolet Is Mediated through Src-dependent Epidermal Growth Factor Receptor Phosphorylation , 2002, The Journal of Biological Chemistry.

[246]  P. Cohen,et al.  MSK1 and MSK2 Are Required for the Mitogen- and Stress-Induced Phosphorylation of CREB and ATF1 in Fibroblasts , 2002, Molecular and Cellular Biology.

[247]  P. Tofilon,et al.  Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization. , 2002, Cancer research.

[248]  Carmel Mothersill,et al.  Relationship between Radiation-Induced Low-Dose Hypersensitivity and the Bystander Effect , 2002, Radiation research.

[249]  J. Contessa,et al.  Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells , 2002, Oncogene.

[250]  M. Sarker,et al.  Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells , 2002, Oncogene.

[251]  C. Arteaga,et al.  Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases , 2002 .

[252]  Mansoor M Ahmed,et al.  Par-4, A Pro-Apoptotic Gene, Inhibits Radiation-Induced NFκB Activity and Bcl-2 Expression Leading to Induction of Radiosensitivity in Human Prostate Cancer Cells PC-3 , 2002, Cancer biology & therapy.

[253]  G. Salvesen,et al.  Apoptosis: IAP proteins: blocking the road to death's door , 2002, Nature Reviews Molecular Cell Biology.

[254]  Altered signaling of TNFalpha-TNFR1 and SODD/BAG4 is responsible for radioresistance in human HT-R15 cells. , 2002, Anticancer research.

[255]  H. Nakshatri,et al.  Identification of signal transduction pathways involved in constitutive NF-κB activation in breast cancer cells , 2002, Oncogene.

[256]  John Calvin Reed,et al.  Dysregulation of apoptosis genes in hematopoietic malignancies , 2002, Oncogene.

[257]  Roy S Herbst,et al.  Epidermal growth factor receptors as a target for cancer treatment: the emerging role of IMC-C225 in the treatment of lung and head and neck cancers. , 2002, Seminars in oncology.

[258]  Liang Qiao,et al.  Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival. , 2002, Frontiers in bioscience : a journal and virtual library.

[259]  N. Guseva,et al.  Contribution of death receptor and mitochondrial pathways to Fas‐mediated apoptosis in the prostatic carcinoma cell line PC3 , 2002, The Prostate.

[260]  T. Mak,et al.  ERK Activation Mediates Cell Cycle Arrest and Apoptosis after DNA Damage Independently of p53* , 2002, The Journal of Biological Chemistry.

[261]  P. Dent,et al.  Phosphorylation of the Myosin-binding Subunit of Myosin Phosphatase by Raf-1 and Inhibition of Phosphatase Activity* , 2002, The Journal of Biological Chemistry.

[262]  J. Ju,et al.  ERK-1/2 and p38 Kinase Oppositely Regulate Nitric Oxide-induced Apoptosis of Chondrocytes in Association with p53, Caspase-3, and Differentiation Status* , 2002, The Journal of Biological Chemistry.

[263]  J. McCubrey,et al.  The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia , 2002, Leukemia.

[264]  Su-Jae Lee,et al.  Protein Kinase C{delta} Overexpression Enhances Radiation Sensitivity via Extracellular Regulated Protein Kinase 1/2 Activation, Abolishing the Radiation-induced G2-M Arrest , 2002 .